1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
Live TV
Latest audioLatest videos
In focus
German coalition collapseDonald TrumpCOP29
Science

Revolution in Medicine - Project BioNTech

November 10, 2021

With the help of mRNA technology, BioNTech has developed a vaccine for COVID-19. These assist the body to produce its own antigens to fight the virus - a medical mile-stone.

https://p.dw.com/p/41Xdv
Biontech
Image: Boris Roessler/dpa/picture alliance

Deutschland I Biontech-Gründer Türeci und Sahin erhalten Bundesverdienstkreuz
Image: Abdulhamid Hosbas/AA/picture alliance

Since the beginning of the 21st century, scientists Uğur Şahin und Özlem Türeci have pursued the goal of creating cancer treatments that are specific to individuals. The firm they established, BioNTech, focuses heavily on revolutionary mRNA technology. 

The "M” in mRNA means ‘messenger and RNA stands for ribonucleic acid. MRNA delivers information for antigen production directly to the cell which produces proteins. Afterwards, these cells present self-produced antigens on their outer shells and trigger a specifically desired immune response. 

Weltspiegel 11.02.2021 | Corona | Deutschland Marburg | Biontech-Werk
Image: BionTech/REUTERS

Şahin and Türeci came up with the idea of using mRNA technology for vaccines in January 2020 after reading about a virus recently identified in Wuhan, China. Within hours, BioNTech decided to launch its search for a viable vaccine. The initial steps required lots of money and nerves of steel. The founders of pharmaceutical giant Hexal, brothers Andreas and Thomas Strünmann, wereamong the first financial backers.

Pfizer-BioNTech COVID-19 Impfstoff
Image: Pfizer/AP Photo/picture alliance

BioNTech received hundreds of millions in funding and the search for a vaccine began. But many questions remained unresolved. In the end, persistence paid off. A Part-nership with Pharma Giant Pfizer sped up the testing phase and the Comirnaty Con-centrate was approved. Its efficacy proven, millions around the world have been vac-cinated with it. 

But what does the future look like for cancer research? And can mRNA technology aid in the fight against Malaria? The documentary shows what a wide-ranging affect this startup company in Mainz, Germany is having on global health. Film maker Michael Schindhelm has gained the opportunity to take a closer look at this revolutionary company. 

Broadcasting Hours: 

DW English

MON 22.11.2021 – 01:15 UTC
MON 22.11.2021 – 04:15 UTC
MON 22.11.2021 – 18:15 UTC
TUE 23.11.2021 – 09:15 UTC
SAT 27.11.2021 – 12:15 UTC
SUN 28.11.2021 – 15:15 UTC

Lagos UTC +1 | Cape Town UTC +2 I Nairobi UTC +3
Delhi UTC +5,5 I Bangkok UTC +7 | Hong Kong UTC +8
London UTC +0 | Berlin UTC +1 | Moscow UTC +3
San Francisco UTC -7 | Edmonton UTC -6 | New York UTC -4

 

DW Deutsch+

TUE 23.11.2021 – 09:15 UTC

Vancouver UTC -8 | New York UTC -5 | Sao Paulo UTC -3